Search research articles
Contact Us
Filters
Showing results (281-290 of 314) with videos related to
Page
of 32
Sort By:
The Lancet. Oncology
|
May 10, 2017
European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas
Michael Weller, Martin van den Bent, Jörg C Tonn, et al.
Research Square
|
October 3, 2025
Newly diagnosed glioblastoma IDHwt patients treated with radiation, nivolumab, and BMS-986205
Derek Wainwright, Rimas Lukas, Lijie Zhai, et al.
The Lancet. Oncology
|
August 1, 2017
Evidence-based management of adult patients with diffuse glioma - Authors' reply
Michael Weller, Martin van den Bent, Jörg C Tonn, et al.
JAMA Oncology
|
January 19, 2017
Molecular-Based Recursive Partitioning Analysis Model for Glioblastoma in the Temozolomide Era: A Correlative Analysis Based on NRG Oncology RTOG 0525
Erica Hlavin Bell, Stephanie L Pugh, Joseph P McElroy, et al.
Neuro-Oncology
|
April 4, 2017
Is more better? The impact of extended adjuvant temozolomide in newly diagnosed glioblastoma: a secondary analysis of EORTC and NRG Oncology/RTOG
Deborah T Blumenthal, Thierry Gorlia, Mark R Gilbert, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 7, 2015
MGMT Promoter Methylation Is a Strong Prognostic Biomarker for Benefit from Dose-Intensified Temozolomide Rechallenge in Progressive Glioblastoma: The DIRECTOR Trial
Michael Weller, Ghazaleh Tabatabai, Bärbel Kästner, et al.
The Lancet. Digital Health
|
October 24, 2021
Deep-learning-based synthesis of post-contrast T1-weighted MRI for tumour response assessment in neuro-oncology: a multicentre, retrospective cohort study
Chandrakanth Jayachandran Preetha, Hagen Meredig, Gianluca Brugnara, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 29, 2023
RANO 2.0: Update to the Response Assessment in Neuro-Oncology Criteria for High- and Low-Grade Gliomas in Adults
Patrick Y Wen, Martin van den Bent, Gilbert Youssef, et al.
JAMA
|
December 21, 2017
Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma: A Randomized Clinical Trial
Roger Stupp, Sophie Taillibert, Andrew Kanner, et al.
The Journal of Clinical Investigation
|
August 29, 2024
B cell-based therapy produces antibodies that inhibit glioblastoma growth
Si Wang, Brandyn A Castro, Joshua L Katz, et al.
Page
of 32
Search research articles
Search
Showing results (281-290 of 314) with videos related to
Sort By:
Page
of 32
The Lancet. Oncology
|
May 10, 2017
European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas
Michael Weller, Martin van den Bent, Jörg C Tonn, et al.
Research Square
|
October 3, 2025
Newly diagnosed glioblastoma IDHwt patients treated with radiation, nivolumab, and BMS-986205
Derek Wainwright, Rimas Lukas, Lijie Zhai, et al.
The Lancet. Oncology
|
August 1, 2017
Evidence-based management of adult patients with diffuse glioma - Authors' reply
Michael Weller, Martin van den Bent, Jörg C Tonn, et al.
JAMA Oncology
|
January 19, 2017
Molecular-Based Recursive Partitioning Analysis Model for Glioblastoma in the Temozolomide Era: A Correlative Analysis Based on NRG Oncology RTOG 0525
Erica Hlavin Bell, Stephanie L Pugh, Joseph P McElroy, et al.
Neuro-Oncology
|
April 4, 2017
Is more better? The impact of extended adjuvant temozolomide in newly diagnosed glioblastoma: a secondary analysis of EORTC and NRG Oncology/RTOG
Deborah T Blumenthal, Thierry Gorlia, Mark R Gilbert, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 7, 2015
MGMT Promoter Methylation Is a Strong Prognostic Biomarker for Benefit from Dose-Intensified Temozolomide Rechallenge in Progressive Glioblastoma: The DIRECTOR Trial
Michael Weller, Ghazaleh Tabatabai, Bärbel Kästner, et al.
The Lancet. Digital Health
|
October 24, 2021
Deep-learning-based synthesis of post-contrast T1-weighted MRI for tumour response assessment in neuro-oncology: a multicentre, retrospective cohort study
Chandrakanth Jayachandran Preetha, Hagen Meredig, Gianluca Brugnara, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 29, 2023
RANO 2.0: Update to the Response Assessment in Neuro-Oncology Criteria for High- and Low-Grade Gliomas in Adults
Patrick Y Wen, Martin van den Bent, Gilbert Youssef, et al.
JAMA
|
December 21, 2017
Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma: A Randomized Clinical Trial
Roger Stupp, Sophie Taillibert, Andrew Kanner, et al.
The Journal of Clinical Investigation
|
August 29, 2024
B cell-based therapy produces antibodies that inhibit glioblastoma growth
Si Wang, Brandyn A Castro, Joshua L Katz, et al.
Page
of 32